DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Jennifer Doudna
Jennifer Doudna
Pomona College Magazine Fall/Winter 2020: the New (Ab
World's Leading Scientists and Technologists to Gather at the Global
Press Release Emmanuelle Charpentier and Jennifer Doudna
PRESS RELEASE August 3, 2020 WINNER of CARL SAGAN PRIZE
Emmanuelle Charpentier
AMA Journal of Ethics® December 2019, Volume 21, Number 12: E1042-1048
Jennifer A. Doudna Adam Grosvirt-Dramen Hochbaum Lab Group Meeting 10/22/2020
Hello, and Welcome to Research Matters Podcasts. Today, I
Summer-Sept 2018 NUCLEUS 8-14-18Web
Wednesday Afternoon Lecture Series 2014–2015
CRISPR As Agent: a Metaphor That Rhetorically Inhibits the Prospects for Responsible Research Leah Ceccarelli
Prof. Emmanuelle Charpentier (France) Dr. Jennifer
Japan Prize 2021
Joachim Frank
Curriculum Vitae Prof. Dr. Emmanuelle Charpentier
INNOVATE Office of the Chief Investment Officer of the Regents
That's the Way the CRISPR Crumbles
2019 in Review Heather Loza Officessistant A
Top View
The Paul Ehrlich Foundation
Jennifer Doudna, Ph.D., and Emmanuelle Charpentier, Ph.D., Win 2014 Dr
Jennifer Doudna Wins 2020 Nobel Prize in Chemistry
The Nai Fellow Profile: an Interview with Dr. Jennifer Doudna
Biography of Jennifer A. Doudna BIOGRAPHY
Pomona College Magazine
The BBVA Foundation Award Goes to James Allison, Creator of the First Immunotherapy to Prove Highly Effective Against Cancer
Should the Rich Be Allowed to Buy the Best Genes? a Letter from Quebec City and Parts West … by WALTER ISAACSON
Of Science, CRISPR-Cas9, and Asilomar - Stanford Law School Page 1 of 8
Lawrence Berkeley National Laboratory Recent Work
May 2016 Asbmb Today 1 President’S Message
OUR PLANET, OUR FUTURE an Urgent Call for Action
Genetic Warfare: Super Humans and the Law
Nobel Laureate Jennifer Doudna and the Bio Revolution Catalyst COLLEGE of CHEMISTRY UNIVERSITY of CALIFORNIA, BERKELEY
Colorado RNA Club Newsletter -- December 2020
A Powerful Legacy of Disseminating Scientific Knowledge
Jennifer Doudna CRISPR–Cas Gene Editors Are Now Both Moving Into the Clinic and Being Embraced As a Means to Find and Validate Drug Targets
Jennifer Doudna's Autobiographical Assessment of The